Expression of tenascin and of the ED-B containing oncofetal fibronectin isoform in human cancer
Authors:
- Sandra SalviSSSandra Salvi
- Gianbattista OliveriGOGianbattista Oliveri
- Laura BorsiLBLaura Borsi
- Patrizia CastellaniPCPatrizia Castellani
- Luciano ZardiLZLuciano Zardi
- 11 December 1990
- journal article
- research article
- Published by Elsevier in Cell Differentiation and Development
- Vol. 32 (3) , 401-408
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Transforming growth factor‐β regulates the splicing pattern of fibronectin messenger RNA precursorFEBS Letters, 1990
- Tenascin: An Extracellular Matrix Protein Prominent in Specialized Embryonic Tissues and TumorsAnnual Review of Cell Biology, 1989
- A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors.Journal of Cell Biology, 1989
- Hexabrachion Protein (Tenascin, Cytotactin, Brachionectin) in Connective Tissues, Embryonic Brain, and TumorsAdvances in Molecular and Cell Biology, 1988
- Tenascin is a stromal marker for epithelial malignancy in the mammary gland.Proceedings of the National Academy of Sciences, 1987
- Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells.Journal of Cell Biology, 1987
- Transformed human cells release different fibronectin variants than do normal cells.Journal of Cell Biology, 1986
- Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesisCell, 1986
- Molecular Biology of FibronectinAnnual Review of Cell Biology, 1985
- The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.Proceedings of the National Academy of Sciences, 1985